The Interaction of Central Nervous System and Acute Kidney Injury: Pathophysiology and Clinical Perspectives
Overview
Authors
Affiliations
Acute kidney injury (AKI) is a common disorder in critically ill hospitalized patients. Its main pathological feature is the activation of the sympathetic nervous system and the renin-angiotensin system (RAS). This disease shows a high fatality rate. The reason is that only renal replacement therapy and supportive care can reduce the impact of the disease, but those measures cannot significantly improve the mortality. This review focused on a generalization of the interaction between acute kidney injury and the central nervous system (CNS). It was found that the CNS further contributes to kidney injury by regulating sympathetic outflow and oxidative stress in response to activation of the RAS and increased pro-inflammatory factors. Experimental studies suggested that inhibiting sympathetic activity and RAS activation in the CNS and blocking oxidative stress could effectively reduce the damage caused by AKI. Therefore, it is of significant interest to specify the mechanism on how the CNS affects AKI, as we could use such mechanism as a target for clinical interventions to further reduce the mortality and improve the complications of AKI. [www.ClinicalTrials.gov], identifier [registration number].
Anteneh Z, Kebede S, Azene A BMC Nephrol. 2025; 26(1):96.
PMID: 40001011 PMC: 11852514. DOI: 10.1186/s12882-025-04024-3.
Nwosu I, Oladiran O, Rivera M, Oladiran O, Nwosu A, Dim C J Community Hosp Intern Med Perspect. 2024; 14(4):18-24.
PMID: 39391106 PMC: 11464058. DOI: 10.55729/2000-9666.1364.
Erfurt S, Lehmann R, Matyukhin I, Marahrens B, Patschan S, Patschan D J Clin Med Res. 2023; 15(2):59-67.
PMID: 36895624 PMC: 9990720. DOI: 10.14740/jocmr4832.
Protective Effects of Orexin A in a Murine Model of Cisplatin-Induced Acute Kidney Injury.
Jo J, Kim J, Leem J J Clin Med. 2022; 11(23).
PMID: 36498769 PMC: 9740499. DOI: 10.3390/jcm11237196.
CNS and CNS diseases in relation to their immune system.
Xu J, Ma C, Hua M, Li J, Xiang Z, Wu J Front Immunol. 2022; 13:1063928.
PMID: 36466889 PMC: 9708890. DOI: 10.3389/fimmu.2022.1063928.